Journal of Integrative Oncology

ISSN: 2329-6771

Open Access

Immunotherapy in Cellular Oncology: Harnessing the Immune System to Fight Cancer


Suie Levi*

Immunotherapy is a revolutionary approach to cancer treatment that harnesses the body's own immune system to recognize, attack, and destroy cancer cells. Unlike traditional cancer treatments such as chemotherapy and radiation therapy, which directly target cancer cells, immunotherapy works by stimulating or enhancing the body's natural immune response against cancer. The immune system is a complex network of cells, tissues, and organs that defends the body against infections and diseases, including cancer. However, cancer cells can sometimes evade detection by the immune system. ver the years, various immunotherapies have been developed and approved for the treatment of different types of cancer. Some of the most notable ones include pembrolizumab and nivolumab (checkpoint inhibitors), as well as CAR T-cell therapies like Kymriah and Yescarta. Immunotherapy has shown remarkable success in treating some types of cancer, leading to long-lasting remissions or even cures in certain patients. It has particularly been effective in melanoma, lung cancer, and some forms of leukemia and lymphoma.


Share this article

Google Scholar citation report
Citations: 495

Journal of Integrative Oncology received 495 citations as per Google Scholar report

Journal of Integrative Oncology peer review process verified at publons

Indexed In

arrow_upward arrow_upward